Image

COMPARISON OF THREE TREATMENT MODALITIES IN MYOFASCIAL PAIN SYNDROME

COMPARISON OF THREE TREATMENT MODALITIES IN MYOFASCIAL PAIN SYNDROME

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

This study aims to compare the effectiveness of dry needling, extracorporeal shock wave therapy (ESWT), and pulsed radiofrequency (PRF) in patients with chronic musculoskeletal pain. The primary outcomes include pain intensity and functional status. Patients will be randomly assigned to different treatment groups, and outcomes will be evaluated before and after the interventions. The results of this study are expected to contribute to determining the most effective treatment method for pain management.

Description

Myofascial pain syndrome is a common musculoskeletal disorder characterized by trigger points and chronic pain. Various treatment modalities such as dry needling, extracorporeal shock wave therapy (ESWT), and pulsed radiofrequency (PRF) are used in clinical practice; however, there is no clear consensus on the most effective approach.

This randomized, parallel-group study aims to compare the effectiveness of these three treatment methods in patients diagnosed with myofascial pain syndrome. Eligible patients aged between 18 and 65 years with chronic back pain lasting at least 3 months will be included in the study. Participants will be randomly assigned to receive dry needling, ESWT, or PRF treatment.

Pain intensity will be assessed using the Numeric Rating Scale (NRS), and functional outcomes will also be evaluated. The study is expected to contribute to the current literature by providing comparative data on these commonly used treatment modalities and guiding clinical decision-making.

Eligibility

Inclusion Criteria:

  • Age between 18 and 65 years
  • Clinically diagnosed myofascial pain syndrome
  • Back pain lasting at least 3 months
  • Failure to respond to conservative treatments

Exclusion Criteria:

  • History of cervical surgery or cervical disc pathology
  • Fibromyalgia
  • Shoulder pathologies
  • Coagulation disorders or use of anticoagulant therapy
  • Infection, malignancy, or inflammatory spinal diseases

Study details
    Myofascial Pain Syndrome

NCT07511751

ALİEMAN

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.